Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of TAP-1503 cream for atopic dermatitis
ChiCTR2400083192Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of TAP-1503 in atopic dermatitis (AD) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: EASI 75 response rate. Started Apr 2024; status: completed.
02
Drugs
TAP-1503
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2400083192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083192.